DRTS Alpha Tau Medical Ltd.

Fundamentals / CIK 0001871321 / USD
Other share classes on CIK 0001871321: DRTSW

Alpha Tau Medical Ltd. reported $105.7M in total assets and a net loss of $42.63M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DRTS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$39.86MFY 2019 Net Income: -$8.37M2019FY 2020 Net Income: -$8.88M2020FY 2021 Net Income: -$27.27M2021FY 2022 Net Income: -$33.76M2022FY 2023 Net Income: -$29.16M2023FY 2024 Net Income: -$31.75M2024FY 2025 Net Income: -$42.63M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $32.06M $27.02M $26.42M $20.89M $11.45M $7.54M $6.64M
Operating Income -$42.29M -$36.04M -$35.68M -$32.14M -$13.79M -$9.24M $8.01M
EBITDA -$41.06M -$34.94M -$34.61M -$31.16M -$13.01M -$9.16M $8.08M
Interest Expense $347K $303K $75K -- -- -- --
Income Before Tax -$42.51M -$31.74M -$29.14M -$33.74M -$27.26M -$8.72M $8.32M
Income Tax Expense $121K $6.0K $16K $20K $7.0K $158K -$146K
Net Income -$42.63M -$31.75M -$29.16M -$33.76M -$27.27M -$8.88M -$8.37M
Basic EPS -$0.53 -$0.45 -$0.42 -$0.53 -$0.67 -$0.22 -$0.25
Diluted EPS -$0.53 -$0.45 -$0.42 -$0.53 -$0.67 -$0.22 -$0.25
Basic Shares Outstanding 80.6M 69.9M 69.4M 63.5M 40.5M 40.3M 33.8M
Diluted Shares Outstanding 80.6M 69.9M 69.4M 63.5M 40.5M 40.3M 33.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for DRTS.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $12.20M $13.72M $12.66M $5.84M $23.24M $15.60M
Short-Term Investments $60.92M $45.88M $69.13M $98.69M $8.08M --
Cash & Short-Term Investments $76.90M $62.85M $84.94M $104.5M $31.32M $15.60M
Total Current Assets $78.30M $64.23M $85.76M $106.5M $32.64M $47.45M
Property, Plant & Equipment, Net $19.66M $13.93M $12.80M $7.47M $7.55M $5.39M
Total Non-Current Assets $27.35M $21.98M $21.63M $13.67M $9.57M $5.53M
Total Assets $105.7M $86.20M $107.4M $120.1M $42.22M $52.99M
Accounts Payable $3.87M $3.53M $2.57M $1.42M $1.20M $964K
Other Current Liabilities -- -- -- -- $3.20M $1.12M
Total Current Liabilities $10.51M $8.68M $7.10M $4.34M $4.41M $2.09M
Total Non-Current Liabilities $18.05M $14.86M $15.81M $10.15M $18.62M $5.37M
Total Liabilities $28.55M $23.54M $22.91M $14.49M $23.03M $7.45M
Total Debt (incl. Leases) $7.37M $6.97M $7.67M $5.19M -- --
Retained Earnings -$190.1M -$147.5M -$115.8M -$86.60M -$52.84M -$25.57M
Total Stockholders' Equity $77.10M $62.67M $84.47M $105.7M -$34.78M -$8.43M
Total Equity $77.10M $62.67M $84.47M $105.7M -$34.78M -$8.43M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Cash & Cash Equivalents $12.20M $13.72M $12.66M $5.84M $23.24M $15.60M
Short-Term Investments $60.92M $45.88M $69.13M $98.69M $8.08M --
Cash & Short-Term Investments $76.90M $62.85M $84.94M $104.5M $31.32M $15.60M
Total Current Assets $78.30M $64.23M $85.76M $106.5M $32.64M $47.45M
Property, Plant & Equipment, Net $19.66M $13.93M $12.80M $7.47M $7.55M $5.39M
Total Non-Current Assets $27.35M $21.98M $21.63M $13.67M $9.57M $5.53M
Total Assets $105.7M $86.20M $107.4M $120.1M $42.22M $52.99M
Accounts Payable $3.87M $3.53M $2.57M $1.42M $1.20M $964K
Other Current Liabilities -- -- -- -- $3.20M $1.12M
Total Current Liabilities $10.51M $8.68M $7.10M $4.34M $4.41M $2.09M
Total Non-Current Liabilities $18.05M $14.86M $15.81M $10.15M $18.62M $5.37M
Total Liabilities $28.55M $23.54M $22.91M $14.49M $23.03M $7.45M
Total Debt (incl. Leases) $7.37M $6.97M $7.67M $5.19M -- --
Retained Earnings -$190.1M -$147.5M -$115.8M -$86.60M -$52.84M -$25.57M
Total Stockholders' Equity $77.10M $62.67M $84.47M $105.7M -$34.78M -$8.43M
Total Equity $77.10M $62.67M $84.47M $105.7M -$34.78M -$8.43M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$42.63M -$31.75M -$29.16M -$33.76M $27.27M $8.88M $8.46M
Depreciation & Amortization $1.23M $1.10M $1.07M $979K $776K $86K $66K
Stock-Based Compensation $10.62M $9.92M $7.93M $6.75M $812K $596K $546K
Change in Payables $337K $965K $1.14M $220K $239K $114K $148K
Operating Cash Flow -$26.68M -$19.78M -$17.96M -$23.88M -$11.81M -$7.25M -$6.91M
Capital Expenditure -$6.08M -$2.24M -$6.40M -$904K -$2.93M -$3.77M -$1.29M
Free Cash Flow -$32.76M -$22.02M -$24.36M -$24.78M -$14.74M -$11.02M -$8.20M
Investing Cash Flow -$20.59M $20.77M $18.68M -$89.94M $19.27M -$7.82M -$10.16M
Common Stock Issued $45.50M -- -- -- -- -- --
Financing Cash Flow $45.77M $25K $5.30M $96.91M $111K $29.32M $5.32M
Net Change in Cash -$1.52M $1.07M $5.97M -$17.17M $7.68M $14.33M -$11.77M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for DRTS.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -55.3% -50.7% -34.5% -32.0% -- -- --
Return on Assets (ROA) -40.3% -36.8% -27.2% -28.1% -64.6% -16.8% --
Current Ratio 7.45x 7.40x 12.07x 24.55x 7.41x 22.73x --
Quick Ratio 7.32x 7.25x 11.96x 24.10x 7.11x 7.47x --
Debt to Equity 0.10x 0.11x 0.09x 0.05x -- -- --
Operating Income Growth (YoY) -- -- -- -- -- -215.4% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for DRTS.
Source: SEC EDGAR CompanyFacts (CIK 0001871321) · from December 31, 2019 Data through December 31, 2025 · synced Nov 20, 2026, 05:28 UTC · Open in terminal